Amgen Inc Stock Guidance

AMGNNASDAQ
$340.18
-4.37-1.27%
At close: Apr 27, 5:00 PM EST
$340.89
0.710.21%
After Hours: 7:59 PM EST
Earnings: Q1 2026 Earnings in 3 days from now on Thu Apr 30th, after the market close
Conference Call: Conference call scheduled in 3 days at 4:30 PM
Click to view the webcast

Amgen (AMGN) last issued guidance on February 3, 2026 for fiscal year 2026. The company guided earnings per share in the range of $21.60 - $23.00, compared to a consensus EPS estimate of $22.02. Amgen also guided revenue in the range of $37.00B - $38.40B for the period.

Compared to prior guidance, Amgen raised its revenue forecast from a prior range of $35.80B - $36.60B.

Amgen has issued 15 guidance updates between August 4, 2022 and February 3, 2026. During this period, the company raised its outlook 6 times, reflecting management's growing confidence in business performance.

Latest Guidance Date
Feb 3, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$21.60 - $23.00
Revenue Guidance Range
$37.00B - $38.40B

Amgen Guidance History

Review all historical guidance issued by Amgen, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

Q

What is the most recent guidance for Amgen (AMGN)?

A

The most recent guidance for Amgen (AMGN) was reported on February 3, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $21.60 to $23.00, compared to the estimated EPS of $22.02. Additionally, Amgen forecasted revenue between $37.00B and $38.40B for the period.

Q

What EPS range did Amgen (AMGN) guide for?

A

Amgen (AMGN) guided EPS in the range of $21.60 to $23.00 for the fiscal year 2026. The consensus analyst EPS estimate is $22.02.

Q

What revenue range did Amgen (AMGN) guide for?

A

Amgen (AMGN) guided revenue in the range of $37.00B to $38.40B for the fiscal year 2026.

Q

Did Amgen (AMGN) raise or lower guidance?

A

Amgen (AMGN) raised its revenue guidance from a prior range of $35.80B - $36.60B to $37.00B - $38.40B for the fiscal year 2026.

Q

When did Amgen (AMGN) last issue guidance?

A

Amgen (AMGN) last issued guidance on February 3, 2026 for the fiscal year 2026.